SuperCrowd
New offering · Form C
A company's offering statement — it's kicking off a Regulation Crowdfunding raise.
Bioclonetics Immunotherapeutics, Inc.
www.bioclonetics.com · TX · Filed Jan 5, 2018
Bioclonetics Immunotherapeutics, Inc. filed a Form C — new offering — with the SEC on Jan 5, 2018. The Regulation Crowdfunding offering seeks $10,000, up to a maximum of $148,234 on StartEngine. Investors receive: Other at $100.00. The offering closes Apr 4, 2018.
| Target raise | $10,000 |
|---|---|
| Maximum raise | $148,234 |
| Security | Other @ $100.00 |
| Closes | Apr 4, 2018 |
| Portal | StartEngine |
| SEC file number | 020-23900 · every filing in this offering |
Filing documents
offeringmemoformc.pdf
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.